IONS vs UNIT · rev $226.6M vs P/E 2.7, rev $722.6M
Ionis Pharmaceuticals Inc (IONS) versus Uniti Group Inc (UNIT) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Uniti Group Inc (UNIT) is a reit - specialty company listed on NASDAQ.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported UNIT revenue for 2025-09-30 was $722.6M. Net income was $1.61B. Revenue was up 147.3% from 2024-09-30 to 2025-09-30. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
IONS currently screens at market cap $12.28B. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
Not investment advice. Open the IONS and UNIT stock pages for the full models.
Not investment advice.